Time to CD20 B-Cell Return After Rituximab in Patients with Antineutrophil Cytoplasmic Antibody Vasculitis
Time to CD20 B-Cell Return After Rituximab in Patients with Antineutrophil Cytoplasmic Antibody Vasculitis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Time to CD20 B-Cell Return After Rituximab in Patients with Antineutrophil Cytoplasmic Antibody Vasculitis have?
Time to CD20 B-Cell Return After Rituximab in Patients with Antineutrophil Cytoplasmic Antibody Vasculitis has 1 citations in the OpenAlex counts ScholarIQ stores.
When was Time to CD20 B-Cell Return After Rituximab in Patients with Antineutrophil Cytoplasmic Antibody Vasculitis published?
Time to CD20 B-Cell Return After Rituximab in Patients with Antineutrophil Cytoplasmic Antibody Vasculitis has 2020 year in the ScholarIQ index.
What is the open-access status of Time to CD20 B-Cell Return After Rituximab in Patients with Antineutrophil Cytoplasmic Antibody Vasculitis?
Time to CD20 B-Cell Return After Rituximab in Patients with Antineutrophil Cytoplasmic Antibody Vasculitis has closed oa status in the ScholarIQ index.
What is the DOI of Time to CD20 B-Cell Return After Rituximab in Patients with Antineutrophil Cytoplasmic Antibody Vasculitis?
The DOI for Time to CD20 B-Cell Return After Rituximab in Patients with Antineutrophil Cytoplasmic Antibody Vasculitis is on the source record.
What is the OpenAlex record for Time to CD20 B-Cell Return After Rituximab in Patients with Antineutrophil Cytoplasmic Antibody Vasculitis?
The OpenAlex for Time to CD20 B-Cell Return After Rituximab in Patients with Antineutrophil Cytoplasmic Antibody Vasculitis is on the source record.